SCHEMBL1974877

SCHEMBL1974877

O=C(O)C1(OCc2ccccc2)C=CC=CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
MAPK1 P28482 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
SLC1A3 P43003 2/20 0.39
SLC1A2 P43004 2/20 0.39
SLC1A1 P43005 2/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
SLC6A2 P23975 1/20 0.37
SLC6A3 Q01959 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
GLA P06280 1/20 0.35
TSHR P16473 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
NR4A1 P22736 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9348319 0.84 CYP2C9 (0.37) ALDH1A1MAPK1L3MBTL1SLC1A3SLC1A2
SCHEMBL11438004 0.79 KCNH2 (0.35) ALDH1A1SLC1A3SLC1A2SLC1A1KMT2A
SCHEMBL2478544 0.76 TSHR (0.36) ALDH1A1MAPK1L3MBTL1SLC1A3SLC1A2
SCHEMBL11483745 0.76
SCHEMBL9017427 0.75 EPHX1 (0.30)
SCHEMBL10489545 0.74 ALDH1A1 (0.36) ALDH1A1MAPK1L3MBTL1SLC1A3SLC1A2
Hydrochloric Acid SCHEMBL9649820 0.73 ALDH1A1 (0.36) ALDH1A1MAPK1L3MBTL1SLC1A3SLC1A2
SCHEMBL6142862 0.73 TSHR (0.36) ALDH1A1MAPK1L3MBTL1SLC1A3SLC1A2
SCHEMBL7116525 0.72 LMNA (0.33) ALDH1A1MAPK1L3MBTL1KMT2AMEN1
SCHEMBL11118507 0.71 ALDH1A1 (0.45) ALDH1A1MAPK1L3MBTL1KMT2ASLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8609699-B2 Oxotetrahydrofuran-2-yl-benzimidazole derivative MSD K.K. (JP) 2013-12-17 US disclosed
EP-2328892-B1 OXOTETRAHYDROFURAN-2-YL-BENZIMIDAZOLE DERIVATIVE MSD KK (JP) 2013-01-16 EP disclosed
US-20110144162-A1 OXOTETRAHYDROFURAN-2-YL-BENZIMIDAZOLE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2011-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110144162-A1 OXOTETRAHYDROFURAN-2-YL-BENZIMIDAZOLE DERIVATIVE GCK, GCKR, KHK ALDH1A1 823/4885MAPK1 1568/4885L3MBTL1 2398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.